282 related articles for article (PubMed ID: 21128748)
1. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease.
Wright JL; Churg A
Expert Rev Respir Med; 2010 Dec; 4(6):723-34. PubMed ID: 21128748
[TBL] [Abstract][Full Text] [Related]
2. Testing drugs in animal models of cigarette smoke-induced chronic obstructive pulmonary disease.
Churg A; Wright JL
Proc Am Thorac Soc; 2009 Sep; 6(6):550-2. PubMed ID: 19741268
[TBL] [Abstract][Full Text] [Related]
3. Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?
Churg A; Sin DD; Wright JL
Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1111-5. PubMed ID: 21685155
[TBL] [Abstract][Full Text] [Related]
4. Experimental COPD induced by solid combustible burn smoke in rats: a study of the emphysematous changes of the pulmonary parenchyma.
Murărescu ED; Eloae-Zugun F; Mihailovici MS
Rom J Morphol Embryol; 2008; 49(4):495-505. PubMed ID: 19050798
[TBL] [Abstract][Full Text] [Related]
5. Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling.
Wright JL; Zhou S; Preobrazhenska O; Marshall C; Sin DD; Laher I; Golbidi S; Churg AM
Am J Respir Crit Care Med; 2011 Jan; 183(1):50-8. PubMed ID: 20709821
[TBL] [Abstract][Full Text] [Related]
6. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.
Yoshida T; Tuder RM
Physiol Rev; 2007 Jul; 87(3):1047-82. PubMed ID: 17615396
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cigarette smoke-induced COPD: insights from animal models.
Churg A; Cosio M; Wright JL
Am J Physiol Lung Cell Mol Physiol; 2008 Apr; 294(4):L612-31. PubMed ID: 18223159
[TBL] [Abstract][Full Text] [Related]
9. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke.
Rivera RM; Cosio MG; Ghezzo H; Salazar M; Pérez-Padilla R
Int J Tuberc Lung Dis; 2008 Aug; 12(8):972-7. PubMed ID: 18647460
[TBL] [Abstract][Full Text] [Related]
10. 3-week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice.
Lee KM; Renne RA; Harbo SJ; Clark ML; Johnson RE; Gideon KM
Inhal Toxicol; 2007 Jan; 19(1):23-35. PubMed ID: 17127640
[TBL] [Abstract][Full Text] [Related]
11. Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease.
Churg A; Marshall CV; Sin DD; Bolton S; Zhou S; Thain K; Cadogan EB; Maltby J; Soars MG; Mallinder PR; Wright JL
Am J Respir Crit Care Med; 2012 Jan; 185(1):34-43. PubMed ID: 21997333
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs.
Lee JH; Lee DS; Kim EK; Choe KH; Oh YM; Shim TS; Kim SE; Lee YS; Lee SD
Am J Respir Crit Care Med; 2005 Oct; 172(8):987-93. PubMed ID: 16002570
[TBL] [Abstract][Full Text] [Related]
13. Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
Seimetz M; Parajuli N; Pichl A; Bednorz M; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Weissmann N
PLoS One; 2015; 10(6):e0129327. PubMed ID: 26058042
[TBL] [Abstract][Full Text] [Related]
14. Development and systematic oxidative stress of a rat model of chronic bronchitis and emphysema induced by biomass smoke.
Hu G; Zhou Y; Hong W; Tian J; Hu J; Peng G; Cui J; Li B; Ran P
Exp Lung Res; 2013 Aug; 39(6):229-40. PubMed ID: 23682816
[TBL] [Abstract][Full Text] [Related]
15. Animal models of chronic obstructive pulmonary disease.
Fricker M; Deane A; Hansbro PM
Expert Opin Drug Discov; 2014 Jun; 9(6):629-45. PubMed ID: 24754714
[TBL] [Abstract][Full Text] [Related]
16. Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice.
Seimetz M; Parajuli N; Pichl A; Veit F; Kwapiszewska G; Weisel FC; Milger K; Egemnazarov B; Turowska A; Fuchs B; Nikam S; Roth M; Sydykov A; Medebach T; Klepetko W; Jaksch P; Dumitrascu R; Garn H; Voswinckel R; Kostin S; Seeger W; Schermuly RT; Grimminger F; Ghofrani HA; Weissmann N
Cell; 2011 Oct; 147(2):293-305. PubMed ID: 22000010
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary inflammatory reaction and structural changes induced by cigarette smoke exposure in the Guinea pig.
Domínguez-Fandos D; Peinado VI; Puig-Pey R; Ferrer E; Musri MM; Ramírez J; Barberà JA
COPD; 2012 Aug; 9(5):473-84. PubMed ID: 22708688
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke alters airway tissue in chronic obstructive pulmonary disease. Lung damage appears to last long after exposure to smoke ends, but quitting at any age has beneficial effects.
Duke Med Health News; 2011 Oct; 17(10):5-6. PubMed ID: 22039625
[No Abstract] [Full Text] [Related]
19. Ghrelin ameliorates catabolic conditions and respiratory dysfunction in a chronic obstructive pulmonary disease model of chronic cigarette smoke-exposed rats.
Kamiide Y; Inomata N; Furuya M; Yada T
Eur J Pharmacol; 2015 May; 755():88-94. PubMed ID: 25771457
[TBL] [Abstract][Full Text] [Related]
20. Animal models of cigarette smoke-induced chronic obstructive lung disease.
Churg A; Wright JL
Contrib Microbiol; 2007; 14():113-125. PubMed ID: 17684336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
